Σλοβενία - Σλοβενικά - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

medias international d.o.o. - glicin; glukoza, brezvodna; glutaminska kislina; histidin; kalcijev klorid; kalijev klorid; alanin; arginin; asparaginska kislina; fenilalanin; izolevcin; levcin; lizin; metionin; prolin; serin; tirozin; treonin; triptofan; valin; magnezijev sulfat; natrijev acetat; natrijev glicerilfosfat; sojino olje, prečiščeno; kalijev klorid - emulzija za infundiranje - glicin 1,6667 mg / 1 ml  glukoza, brezvodna67,5 mg / 1 ml  glutaminska kislina1,1667 mg / 1 ml  histidin1,4167 mg / 1 ml  kalcijev klorid0,1542 mg / 1 ml  kalijev klorid1,25 mg / 1 ml  alanin3,3333 mg / 1 ml  arginin2,3333 mg / 1 ml  asparaginska kislina0,7083 mg / 1 ml  fenilalanin1,6667 mg / 1 ml  izolevcin1,1667 mg / 1 ml  levcin1,6667 mg / 1 ml  lizin1,875 mg / 1 ml  metionin1,1667 mg / 1 ml  prolin1,4167 mg / 1 ml  serin0,9167 mg / 1 ml  tirozin0,05 mg / 1 ml  treonin1,1667 mg / 1 ml  triptofan0,3958 mg / 1 ml  valin1,5 mg / 1 ml  magnezijev sulfat0,3333 mg / 1 ml  natrijev acetat1 mg / 1 ml  natrijev glicerilfosfat1,0417 mg / 1 ml  sojino olje, prečiščeno35,4167 mg / 1 ml  kalijev klorid1,25 mg / 1 ml; glukoza, brezvodna 67,5 mg / 1 ml  glutaminska kislina1,1667 mg / 1 ml  histidin1,4167 mg / 1 ml  kalcijev klorid0,1542 mg / 1 ml  kalijev klorid1,25 mg / 1 ml  alanin3,3333 mg / 1 ml  arginin2,3333 mg / 1 ml  asparaginska kislina0,7083 mg / 1 ml  fenilalanin1,6667 mg / 1 ml  izolevcin1,1667 mg / 1 ml  levcin1,6667 mg / 1 ml  lizin1,875 mg / 1 ml  metionin1,1667 mg / 1 ml  prolin1,4167 mg / 1 ml  serin0,9167 mg / 1 ml  tirozin0,05 mg / 1 ml  treonin1,1667 mg / 1 ml  triptofan0,3958 mg / 1 ml  valin1,5 mg / 1 ml  magnezijev sulfat0,3333 mg / 1 ml  natrijev acetat1 mg / 1 ml  natrijev glicerilfosfat1,0417 mg / 1 ml  sojino olje, prečiščeno35,4167 mg / 1 ml  kalijev klorid1,25 mg / 1 ml; glutaminska kislina 1,1667 mg / 1 ml  histidin1,4167 mg / 1 ml  kalcijev klorid0,1542 mg / 1 ml  kalijev klorid1,25 mg / 1 ml  alanin3,3333 mg / 1 ml  arginin2,3333 mg / 1 ml  asparaginska kislina0,7083 mg / 1 ml  fenilalanin1,6667 mg / 1 ml  izolevcin1,1667 mg / 1 ml  levcin1,6667 mg / 1 ml &nbs - kombinacije

Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

the medicines company uk ltd - bivalirudin - akutni koronarni sindrom - antitrombotična sredstva - angiox je indiciran kot antikoagulant pri odraslih bolnikih s perkutano koronarnim posegom (pci), vključno z bolniki z miokardnim infarktom elevacije st (stemi), ki se podvrže primarni pci. angiox je prikazano tudi za zdravljenje odraslih bolnikov z nestabilno angino pektoris / non-st-segmenta,-dvig miokardni infarkt (ua / nstemi) načrtovana za nujne ali zgodnje intervencije. angiox je treba dajati z aspirinom in clopidogrel.

Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

pharmathen s.a. - memantinijev klorid - alzheimerjeva bolezen - psychoanaleptics, , druge anti-demenco zdravila - zdravljenje bolnikov z zmerno do hudo alzheimerjevo boleznijo.

Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

pharmathen s.a. - enoksaparin natrij - venska tromboembolija - antitrombotična sredstva - thorinane je primerna za odrasle za: - za preventivo venske thromboembolism, še posebej pri bolnikih, ki opravljajo ortopedske, splošne ali onkoloških operacijo. - za preventivo venske thromboembolism pri bolnikih, vezan na posteljo zaradi akutne bolezni, vključno z akutno srčno popuščanje, akutna dihalna odpoved, hude okužbe, kot tudi akutne revmatske bolezni, ki povzročajo imobilizacijo bolnika (velja za prednosti 40 mg/0. 4 ml). - zdravljenje globoke venske tromboze (dvt), zapletena ali pa enostavno za pljučna embolija. - zdravljenje nestabilne angine in ne q val miokardni infarkt, v kombinaciji z acetilsalicilne kisline (asa). - zdravljenje akutne st segmentu višinskih miokardni infarkt (stemi), vključno z bolniki, ki bodo zdravljeni konzervativno ali ki se bo kasneje prihajalo perkutani koronarni angioplastiko (velja za prednosti 60 mg/0. 6 ml, 80 mg/0. 8 ml in 100 mg/1 ml). - krvni strdek preprečevanje extracorporeal obtoku med hemodializo. preprečevanje in zdravljenje različnih bolezni, povezanih s krvnih strdkov pri odraslih.

Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

biogen netherlands b.v. - natalizumab - multiple skleroza - selektivni imunosupresivi - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 in 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

insmed netherlands b.v. - amikacin sulfate - okužbe dihalnih poti - antibacterials za sistemsko uporabo, - arikayce liposomal is indicated for the treatment of non-tuberculous mycobacterial (ntm) lung infections caused by mycobacterium avium complex (mac) in adults with limited treatment options who do not have cystic fibrosis.

Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - druga zdravila na živčnem sistemu - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.

Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - imunologija za aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - piščanec - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - imunosupresivi - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).